APYX

Apyx Medical Corporation

$2.93

-0.34%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.

Source: Yahoo Finance
AI summary

Price & performance

1M-20.9%
3M-43.5%
YTD-30.9%
1Y-17.1%
52-week range—
Beta1.44
Full chart and returns against a benchmark

Q-Score

50/ 100

Quality against peers; 50 is the peer median.

Growth50
Risk48
Performance56
Valuation48
Profitability57
Leverage41
Sentiment69
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$52.8M+9.9%
Net income-$11.2M
Net margin-21.2%+27.6 pts
Historical fundamentals

Revenue exposure

27%of revenue from outside the US
United States73%
Non Us27%
Regions, segments, customers and suppliers

Valuation

APYXIndustryP/E—29.61P/S2.073.49EV/EBITDA—18.38P/B12.823.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 5next report, before the open
EPS estimate$-0.09
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate